SuperworthRocket One EPS RKTO
Diluted earnings per share by quarter and over the last twelve months, from 2018.
- Last 12 months, to Jun 30, 2026
- −$0.83
- Latest quarter, Q2 FY26
- −$0.19
- Fiscal year 2025
- −$0.91
Rocket One's earnings per share was −$0.83 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.19.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.91 | n/a |
| FY2024 | −$1.35 | n/a |
| FY2023 | −$2.46 | n/a |
| FY2022 | −$9.57 | n/a |
| FY2021 | −$16.75 | n/a |
| FY2020 | −$15.00 | n/a |
| FY2019 | −$20.25 | n/a |
| FY2018 | −$12.50 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.19 | n/a | −$0.83 | |
| Q1 FY26 | −$0.17 | n/a | −$0.81 | |
| Q4 FY25 | −$0.17 | n/a | −$0.91 | |
| Q3 FY25 | −$0.30 | n/a | −$1.03 | |
| Q2 FY25 | −$0.17 | n/a | −$1.05 | |
| Q1 FY25 | −$0.27 | n/a | −$1.13 | |
| Q4 FY24 | −$0.29 | n/a | −$1.35 | |
| Q3 FY24 | −$0.32 | n/a | −$1.47 | |
| Q2 FY24 | −$0.25 | n/a | −$1.75 | |
| Q1 FY24 | −$0.49 | n/a | −$2.07 | |
| Q4 FY23 | −$0.41 | n/a | −$2.46 | |
| Q3 FY23 | −$0.60 | n/a | −$4.73 |
Against its peers
Companies in Drug Manufacturers - General nearest Rocket One's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| RKTORocket One | −$0.83 | |
| ATNMActinium Pharmaceuticals | $0.36 | |
| SPROSpero Therapeutics | $0.11 | |
| LFVNLifevantage | $0.40 | −46% a year |
| Peer median | $0.36 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Rocket One
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.